The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Clinical trials (3)
- Advertising (248)
- Medicine safety (158)
- COVID-19 (144)
- Prescription medicines (136)
- Regulatory compliance (124)
- COVID-19 vaccines (88)
- Legislation (81)
- Therapeutic goods regulation (72)
- Listed medicines (52)
- Safety (49)
- Non-prescription medicines (48)
- Medical devices safety (43)
- Vaping hub (39)
- Complementary medicines (32)
- Manufacturing (31)
- Labelling and packaging (28)
- Assessed listed medicines (25)
- Over the counter (OTC) medicines (24)
- Scheduling (national classification system) (24)
- Compliance and enforcement hub (22)
- Australian Register of Therapeutic Goods (ARTG) (20)
- Medicinal cannabis hub (20)
- Import and export (19)
- Alert/Advisory (17)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (8)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
3 result(s) found, displaying 1 to 3
-
NewsThe updated plan emphasises solidifying our collaborative processes, aligning expectations with industry, and improving our communication strategies.
-
NoticesThis instrument is made under the Therapeutic Goods Regulations 1990 and the Therapeutic Goods (Medical Devices) Regulations 2002.
-
NewsWe are reviewing the safety information supporting notifications of the highest-risk medical devices used in first-in-human clinical trials. Find out how the changes we have implemented impact you as a sponsor.